Physician profile
Rukmini Samamritha Rednam
NPI 1477706463
$112,731.28
in general payments reported to CMS, 2019-2025
22 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $628 · 2021: $1,240 · 2022: $32K · 2023: $27K · 2024: $33K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Consulting Fee: $22K · Travel and Lodging: $7,716 · Food and Beverage: $5,707 · Long Term Medical Supply Or Device Loan: $326 · Gift: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,756.25 |
| Consulting Fee | $22,311.21 |
| Travel and Lodging | $7,715.74 |
| Food and Beverage | $5,706.97 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Gift | $120.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $70,164.35 | 2023-2025 | |
| Allergan, INC. | $30,922.52 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $4,119.80 | 2021-2025 | Exparel, Iovera |
| Motiva USA, LLC | $3,290.75 | 2024-2025 | |
| Mentor Worldwide LLC | $1,221.93 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $709.25 | 2021-2025 | Phasix Mesh |
| Galderma Laboratories, L.P. | $496.56 | 2020-2025 | |
| Integra Lifesciences Corporation | $427.53 | 2021-2024 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Inspire Medical Systems, INC. | $294.67 | 2023-2025 | Inspire |
| Musculoskeletal Transplant Foundation INC. | $290.42 | 2019-2022 | |
| Tepha INC | $199.37 | 2019 | |
| Revance Therapeutics, INC. | $151.67 | 2024-2025 | Daxxify |
| Rti Surgical, INC | $102.05 | 2024 | |
| Sientra, INC. | $99.52 | 2022 | |
| Kci USA, INC. | $63.79 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $48.88 | 2024-2025 | |
| Genzyme Corporation | $38.57 | 2024 | |
| Smith+Nephew, INC. | $29.69 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.58 | 2024 | Dupixent |
| Olympus America INC. | $16.75 | 2023 | |
| Heron Therapeutics, INC. | $13.20 | 2024 | Zynrelef |
| Coopersurgical, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rukmini Rednam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.